Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Flow Sciences Taps Board Member Michael Gesser as New CFO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Flow Sciences Taps Board Member Michael Gesser as New CFO

Gesser will continue to serve on the Board of Directors while assuming certain executive responsibilities.

Author Image

By: Patrick Lavery

Content Marketing Editor

Flow Sciences, which provides advanced containment solutions for pharmaceutical and laboratory environments, is naming Michael Gesser Chief Financial Officer (CFO).

Gesser has been a member of Flow Sciences’ Board of Directors since 2021. He will continue as such while CFO, adding finance, accounting, tax, treasury, financial planning and analysis, and investor relations responsibilities.

How Flow Sciences Will Deploy New CFO

Working with Flow Sciences’ executive team, Gesser will now oversee financial strategy, capital structure management, budgeting, forecasting, and compliance. He will also support ongoing growth initiatives, building on award-winning company innovations such as the Vented Balance Safety Enclosure.

“Michael’s appointment as CFO is a natural evolution of his already-significant contributions,” said Flow Sciences CEO Jonathan Mann.

Mann praised Gesser’s “deep financial expertise,” “experience navigating both public and private company environments,” and “long-standing familiarity with our business.”

“I have had a front-row seat to Flow Sciences’ evolution,” Gesser said. He cited “the strength of its technology, the quality of its team, and the depth of its customer relationships.”

Gesser’s Impact Prior to CFO Appointment

Flow Sciences is headquartered in North Carolina. While on its board, Gesser has had a role in the company’s expansion into the state’s Research Triangle Park section. That office opened in 2025 and boasts a state-of-the-art product showroom, training facilities, and consultative design center.

Additionally, this is not Gesser’s first appointment as a CFO. He has previously served in that role for Acorda Therapeutics, Osmotica Pharmaceutical, Tergus Pharma, BioMedomics, and SunTech Medical.

He now takes the financial reins as Flow Sciences seeks to expand its containment solutions portfolio

“There is a tremendous opportunity ahead of us, and I look forward to helping the company capitalize,” Gesser said.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics